Application due dates on or after June 5, 2023 and subsequent receipt dates through July 5, 2025.
This Notice of Special Interest (NOSI) aims to accelerate a comprehensive understanding of the mechanisms of COVID-19-Associated Coagulopathy (CAC) which are provoked by vascular endothelial cell injury, hyperimmune responses, and hypercoagulability at genomic, molecular, and cellular levels.
Knowledge obtained from such studies may be applied to the future design of early diagnostics and effective treatment for high-risk patients as well as enable CAC research findings to be applied to on-going COVID-19 clinical trials.
Topics: Biomarkers, Clinical Presentation of Infection, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Co-Morbidities, Cardiovascular Disease, COVID-19, Diabetes, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Community Engagement, Computational or Data Science Methods Development, Epidemiology, Clinical History, Clinical Outcome, Risk Factors, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Organ, Brain, Endocrine, GI, Heart, Cardiovascular, Kidney, Liver, Lung, Prognostics, Research Methods, Cell Culture, Electronic Health Records (EHR), Imaging, Immunofluorescence, Screen, Sequencing, Research Model Development, Research Models, Mouse Models, Non-Human Animal Models, Organoid Models, Virology, Viral Interactome, Viral Proteins, Virus Factors, Research Tool Development